The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
97809775 9780977 5 F 20130603 20160805 20131224 20160810 EXP JP-SA-2013SA132698 AVENTIS 30.00 YR A F Y 56.30000 KG 20160810 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
97809775 9780977 1 PS THYMOGLOBULINE LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN 1 Intravenous (not otherwise specified) UNKNOWN 103869 68 MG POWDER FOR SOLUTION FOR INFUSION QD
97809775 9780977 2 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 0
97809775 9780977 3 C TAKEPRON LANSOPRAZOLE 1 0
97809775 9780977 4 C URSO URSODIOL 1 0
97809775 9780977 5 C LASIX FUROSEMIDE 1 0
97809775 9780977 6 C VALTREX VALACYCLOVIR HYDROCHLORIDE 1 0
97809775 9780977 7 C BIOFERMIN R BACILLUS SUBTILISLACTOBACILLUS ACIDOPHILUSSTREPTOCOCCUS FAECAIS 1 0
97809775 9780977 8 C MAXIPIME CEFEPIME HYDROCHLORIDE 1 0
97809775 9780977 9 C FUNGUARD MICAFUNGIN SODIUM 1 0
97809775 9780977 10 C SOL-MELCORT METHYLPREDNISOLONE SODIUM SUCCINATE 1 0
97809775 9780977 11 C MORPHINE HYDROCHLORIDE MORPHINE HYDROCHLORIDE 1 0 INJECTION
97809775 9780977 12 C FRAGMIN DALTEPARIN SODIUM 1 0
97809775 9780977 13 C EMEND APREPITANT 1 0
97809775 9780977 14 C FLUDARA FLUDARABINE PHOSPHATE 1 0
97809775 9780977 15 C GRANISETRON GRANISETRON 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
97809775 9780977 1 Bone marrow conditioning regimen
97809775 9780977 2 Prophylaxis against graft versus host disease
97809775 9780977 3 Gastrooesophageal reflux disease
97809775 9780977 4 Drug-induced liver injury
97809775 9780977 5 Oedema
97809775 9780977 6 Antiviral prophylaxis
97809775 9780977 7 Vomiting
97809775 9780977 8 Prophylaxis
97809775 9780977 9 Antifungal prophylaxis
97809775 9780977 10 Prophylaxis
97809775 9780977 11 Stomatitis
97809775 9780977 12 Prophylaxis
97809775 9780977 13 Vomiting
97809775 9780977 14 Bone marrow conditioning regimen
97809775 9780977 15 Vomiting

Outcome of event

Event ID CASEID OUTC COD
97809775 9780977 HO
97809775 9780977 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
97809775 9780977 Acute lymphocytic leukaemia recurrent
97809775 9780977 Febrile neutropenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
97809775 9780977 1 20130603 20130604 0
97809775 9780977 2 20130603 20131120 0
97809775 9780977 5 20130509 20130613 0
97809775 9780977 6 20130509 20130719 0
97809775 9780977 7 20130619 0
97809775 9780977 8 20130520 20130607 0
97809775 9780977 9 20130530 20130613 0
97809775 9780977 10 20130603 20130705 0
97809775 9780977 11 20130526 20130622 0
97809775 9780977 12 20130529 20130708 0
97809775 9780977 13 20130530 20130603 0
97809775 9780977 14 20130530 20130603 0
97809775 9780977 15 20130530 20130603 0